Multidisciplinary Obesity Care Programme With Semaglutide and Behavioral Treatment in Adults
Tests a team-based obesity care programme, including semaglutide, in adults living with obesity.
Plain-language title generated from the registry record
Registry title: OBESIAL: A Prospective Interventional Real-world Study of a Multidisciplinary Obesity Management Programme
Key facts
- Where
- Algiers, AlgeriaSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with obesity to test a structured care programme run by several health professionals, in real-life conditions.
- Age
- 18 to 65 years
- Sex
- All sexes
- Disease stage
- Obesity with a BMI of 30 kg/m² or higher
- Earlier treatment
- Cannot have had bariatric surgery or obesity medicine in the previous 90 days
Main reasons for not taking part
- Pregnant at enrolment
- Recent acute heart or blood vessel event (less than 60 days ago)
- Active cancer
- Previous bariatric surgery
- Genetic obesity or obesity caused by uncontrolled hormone disease
Read by machine on 9 November 2026.
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 65 years old?
Source: NCT07779343, who can take part
Where in Algeria
- Department of Medicine, , Mother and Child Hospital of the Army (MCHA), Algiers University Hospital, Algiers, Algeria.Algiers, AlgeriaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University of Health Sciences, Algeria
- Trial code
- NCT07779343
- Record updated
- 21 August 2026
- Original description
The OBESIAL (Obesity Structured Intervention in Algeria) study aims to evaluate the clinical, metabolic, and organisational impact of a structured multidisciplinary obesity care pathway implemented under real-world conditions.Read full original descriptionShow less
OBESIAL: A Prospective Interventional Real-world Study of a Multidisciplinary Obesity Management Programme
The OBESIAL (Obesity Structured Intervention in Algeria) study aims to evaluate the clinical, metabolic, and organisational impact of a structured multidisciplinary obesity care pathway implemented under real-world conditions.
Inclusion: Adults aged 18-65 years; BMI ≥30 kg/m²; Written informed consent obtained prior to enrolment.
Exclusion: Previous bariatric surgery; Obesity pharmacotherapy within the previous 90 days; Severe or unstable comorbidities compromising safety or participation, including:; Recent acute cardiovascular event (<60 days); Active malignancy; Severe unstable organic disease; Severe unstable psychiatric disorders; Genetic obesity or obesity secondary to uncontrolled endocrine disease; Refusal to participate or inability to adhere to follow-up procedures; Pregnancy at enrolment; Known contraindication to planned therapeutic options; Pregnancy occurring during follow-up; Initiation of chronic treatment associated with weight gain.